// App-Quantinova.ai

464 : JAKINIB in Refractory Giant Cell Arteritis. National Multicenter Study of 15 Cases and Literature Review

Researchers

Presenter

  • Diana Prieto-Peña

Principal Investigators

  • Javier Loricera

  • Susana Romero Yuste

  • Anne Riveros-Frutos

  • F. Javier Narváez

  • Eugenio De Miguel

  • Valentina Emperiale

  • Elena Becerra-Fernández

  • Santos Castañeda

  • Eztizen Labrador

  • Olga Maiz

  • Miguel Ángel González-Gay

  • Ricardo Blanco

Medical Centers

  • IDIVAL, Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Santander, Spain

  • Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

  • Complexo Hospitalario Universiotario de Pontevedra, Vigo, Spain

  • Hospital Universitari Germans Trias i Pujol, Badalona, Spain

  • Immunology Department. Hospital Universitari de Bellvitge, Barcelona, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital Principe de Asturias, Alcala de Henares, Spain

  • Hospital Universitario de Torrevieja, London, United Kingdom

  • Rheumatology, Hospital Universitario de La Princesa. IIS-Princesa, Madrid, Madrid, Spain

  • Hospital San Pedro, Logrono, Spain.

  • Hospital Universitario Donostia, San Sebastian, Spain

  • Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla; Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Locations

  • United States

  • Spain

  • United Kingdom

  • South Africa

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

Disease

  • Giant cell arteritis

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

  • Tocilizumab

  • Baricitinib

  • BARI

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A